BLOOMBERG NEWS INTERVIEW OF IMMUNEX CEO AT 2 P.M.
BLOOMBERG NEWS INTERVIEW OF IMMUNEX CEO AT 2 P.M. Stephen A. Duzan, the CEO of Immunex Corp. (NASDAQ: IMNX), a
biopharmaceutical company, will discuss the outlook for his company at 2:00 p.m. in the Bloomberg Center, 499 Park Avenue, 15th floor, New York. This is the first in a series of Bloomberg interviews with company officials.
Immunex Corp.'s stock rose approximately 5 points Wednesday. Some of the company's products under development have applications in cancer therapy and treating infectious autoimmune and inflammatory diseases. The Bloomberg Center is a state-of-the-art multi media center available for conferences, seminars, interviews and news meetings. CONTACT: Elisabeth DeMarse of Bloomberg Financial Markets, 212-318-2024. -0- 1/30/92 (IMNX) CO: IMMUNEX Corp. ST: New York IN: MTC SU: ECO
TS-SM -- NY001B -- 5239 01/30/92 12:23 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 30, 1992|
|Previous Article:||THE TRUSTCOMPANY BANCORPORATION REPORTS RECORD EARNINGS|
|Next Article:||HUMAN RESOURCE CONCERNS SHIFT FOR 1992, BNA SURVEY FINDS|